Results 11 to 20 of about 1,935,200 (187)

Drug-eluting stents : Insights into safety and indications

Annals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj   +2 more sources

Everolimus-eluting stents: update on current clinical studies

Medical Devices: Evidence and Research, 2011
Dominic J Allocco, Anita A Joshi, Keith D DawkinsBoston Scientific Corporation, Natick, MA, USAAbstract: Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide.
Allocco DJ, Joshi AA, Dawkins KD
doaj   +1 more source

Promoting vascular healing using nanofibrous ticagrelor-eluting stents

International Journal of Nanomedicine, 2018
Cheng-Hung Lee,1 Ming-Jer Hsieh,1 Kuo-Sheng Liu,2,3 Che-Wei Cheng,3 Shang-Hung Chang,1 Shih-Jung Liu,3,4 Chao-Jan Wang,5 Ming-Yi Hsu,5 Kuo-Chun Hung,1 Yung-Hsin Yeh,1 Wei-Jan Chen,1 I-Chang Hsieh,1 Jyuhn-Huarng Juang,6 Ming-Shien Wen1 1Division of ...
Lee CH, Hsieh MJ, Liu KS, Cheng CW, Chang SH, Liu SJ, Wang CJ, Hsu MY, Hung KC, Yeh YH, Chen WJ, Hsieh IC, Juang JH, Wen MS   +13 more
doaj   +1 more source

Everolimus-eluting coronary stents

Medical Devices: Evidence and Research, 2010
Alejandro Saez, Raul MorenoDivision of Interventional Cardiology, University Hospital La Paz, Madrid, SpainAbstract: Bare metal stents enabled a reduction in the risk of early procedural complications and restenosis in comparison with balloon angioplasty
Alejandro Saez, Raul Moreno
doaj   +1 more source

Comparative outcomes of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. [PDF]

Arch Med Sci Atheroscler Dis
Introduction Several treatment modalities have been proposed and used for bare-metal in-stent restenosis (ISR). We compared the efficacy of drug-eluting balloons (DEB) versus drug-eluting stents (DES) in the treatment of ISR in terms of binary restenosis,
Mahajan N, Singal G, Sharma M.
europepmc   +2 more sources

A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model

Frontiers in Pharmacology, 2023
Introduction: Most drug-eluting stents (DESs) inhibit intimal hyperplasia but impair re-endothelialization. This study aimed to evaluate in vivo strut coverage and neointimal growth in a new glycyrrhizin acid (GA)-eluting stent.Methods: New Zealand White
Shuai Teng, Zhaowei Zhu, Yang Li, Xinqun Hu, Zhenfei Fang, Zhenjiang Liu, Shenghua Zhou   +6 more
doaj   +1 more source

Comparison of Clinical Outcomes Between Second-and First-Generation Drug-Eluting Stents in Patients With Chronic Total Occlusion Lesion: A Meta-Analysis

Frontiers in Cardiovascular Medicine, 2021
Background and Objectives: The second-generation drug-eluting stents have been used to treat chronic total occlusion lesion. However, there is limited evidence of the clinical outcomes that whether the second-generation drug-eluting stents is superior to
Xuan Qiao, Wen-Jiao Zhang, Wen-Fen Guo, Yan Li, Xi-Ying Liang, Zhi-Lu Wang   +5 more
doaj   +1 more source

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]

, 2007
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J, Schampaert, Erick, Dawkins, Keith D, Morice, Marie-Claude, Pocock, Stuart J, Fahy, Martin, Stone, Gregg W, Colombo, Antonio, Moses, Jeffrey W, Cutlip, Donald E, Ellis, Stephen G, Grube, Eberhard, Leon, Martin B, Mehran, Roxana, Schofer, Joachim   +14 more
core   +1 more source

Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Results We
Scott Kinlay, Lien Quach, Jean Cormack, Natalie Morgenstern, Ying Hou, Melissa Young, Rebecca Sherrod, Kelly Cho, David P. Faxon, Ronnie Ramadan, Michael Gaziano, David Gagnon   +11 more
doaj   +1 more source

The role of optical coherence tomography guidance in scaffold versus stent optimization

The Egyptian Heart Journal, 2020
Background Optical coherence tomography showed a great ability to identify adverse features during percutaneous coronary intervention with drug-eluting stents and resulted in better clinical outcomes.
Arif A. Al Nooryani, Nagwa A. Abdelrahman, Hatem A. Helmy, Yehia T. Kishk, Ayman K. M. Hassan   +4 more
doaj   +1 more source